Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Nov 2015 · 1 min read
In brief
In brief
This prospective multicenter study of 242 adolescents demonstrates sustained weight loss (27% mean reduction) and high remission rates of obesity-related comorbidities including type 2 diabetes (95%) and abnormal kidney function (86%) at 3 years following Roux-en-Y gastric bypass or sleeve gastrectomy.
Written by the GCMD Library team from the article.
Statements in this article
The study enrolled 242 adolescents undergoing weight-loss surgery at five U.S. centers, with 161 undergoing Roux-en-Y gastric bypass and 67 undergoing sleeve gastrectomy.
The mean baseline age of participants was 17±1.6 years, mean body-mass index was 53, 75% were female, and 72% were white.
At 3 years after bariatric surgery, mean weight decreased by 27% (95% CI, 25 to 29) in the total cohort.
At 3 years, participants who underwent gastric bypass had a mean weight decrease of 28% (95% CI, 25 to 30).
At 3 years, participants who underwent sleeve gastrectomy had a mean weight decrease of 26% (95% CI, 22 to 30).
Remission of type 2 diabetes occurred in 95% (95% CI, 85 to 100) of participants who had the condition at baseline by 3 years after the procedure.
Remission of abnormal kidney function occurred in 86% (95% CI, 72 to 100) of affected participants by 3 years after the procedure.
Remission of prediabetes occurred in 76% (95% CI, 56 to 97) of affected participants by 3 years after the procedure.
